Prot# NLG-0205: A Phase II Study of HyperAcute-Pancreatic Cancer Vaccine in Subjects with Surgically Resected Pancreatic Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date11/12/07 → 11/12/10

Funding

  • NewLink Genetics Corporation (NLG-0205)